share_log

Needham Maintains Buy on Phathom Pharmaceuticals, Maintains $26 Price Target

Moomoo 24/7 ·  Mar 15 10:34

Needham analyst Joseph Stringer maintains Phathom Pharmaceuticals (NASDAQ:PHAT) with a Buy and maintains $26 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment